Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A in Herpetic Stromal Keratitis
NCT05720715Phase 4Completed
- Sponsor
- Farwaniya Hospital
- Start
- Jan 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution in herpetic stromal keratitis (HSK), sponsored by Farwaniya Hospital. Started Jan 2022; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
herpetic stromal keratitis (HSK)
Beyond the preview
Go deeper on NCT05720715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05720715.